X PARSOLEX PARTNER SOLUTIONS EXCELLENCE
Live / Registered — Registered (as of 18 May 2021)
What this means for you
Registered since 18 May 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88570483
- Registration number
- 6356727
- Mark type
- Design + words
- Filed
- 07 Aug 2019
- Published for opposition
- 28 Jul 2020
- Registered
- 18 May 2021
- Attorney of record
- Jill J. Chalmers
Goods and services
- Class 042 — Scientific and technological services: Consulting services in the fields of pharmaceutical, medical and healthcare research and development; technical services, namely, research and development in the pharmaceutical and biotechnology fields; consulting services for pharmaceutical formulation design, design of processes to transform inorganic and organic substances and pharmaceutical technology transfer being advice and information about pharmaceutical research and design; technical services, namely, providing advice, information and instructions for pharmaceutical formulation design and design of processes to transform inorganic and organic substances, pharmaceutical technology transfer being advice and information about pharmaceutical research and design; pharmaceutical product chemical and physical evaluation services, namely, test method development, test method validation, use of test methods for in-process control, quality control, and product release, and technology transfer being advice and information about pharmaceutical test methods; analytical chemistry services, namely, developing and validating test methods for drug product release; technology transfer being advice and information about the drug product testing process and test methods; providing services to others in the fields of analytical, chemistry and manufacturing controls for the production and regulatory approval of pharmaceuticals, namely, providing scientific information relating to the analysis and management of the pharmaceutical manufacturing process for the production, packaging, and regulatory approval of pharmaceuticals; consulting services in the fields of chemistry, biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; consulting and research and development services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; technical consulting in the fields of pharmaceutical studies, research and development; technical consulting in the field of pharmaceutical development and engineering; technical consulting in the field of analytical chemistry services; consultancy pertaining to pharmacology; technology consultation in the fields of research and development of pharmaceuticals, medicines and healthcare products; scientific research consulting in the fields of pharmaceuticals, medicines and healthcare products; product development consulting in the fields of pharmaceuticals, medicines and healthcare products; scientific research services relating to pharmaceuticals, medicines and healthcare products; product development consultation; product development services; formulation and process design services for drug products for others; outsource service provider for manufacturing and packaging of pharmaceuticals; formulation and process design services for drug products for others; design of packaging for pharmaceuticals of others; pharmaceutical product packaging design services for others; formulation and process design services for drug products of others; provision of information, advice and consultancy in relation to pharmaceutical packaging design; technical consulting in the field of pharmaceutical research and development; custom pharmaceutical service provider, namely, pharmaceutical formulation design, design of processes to transform inorganic and organic substances, and chemical and physical evaluation of pharmaceuticals; consulting in the areas of pharmaceutical formulation design, design of processes to transform inorganic and organic substances, and chemical and physical evaluation of pharmaceuticals; development of custom pharmaceuticals for others; design of packaging for pharmaceuticals for others; formulation and process design services for drug products for others
Owner
- Parsolex GMP Center, Inc., West Lafayette, IN, US
- Parsolex GMP Center, Inc., West Lafayette, IN, US
- Parsolex GMP Center, Inc., West Lafayette, IN, US
Prosecution history
- 18 May 2021 — REGISTERED-PRINCIPAL REGISTER
- 16 Apr 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Apr 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Apr 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Mar 2021 — USE AMENDMENT FILED
- 01 Apr 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Mar 2021 — TEAS STATEMENT OF USE RECEIVED
- 22 Sept 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jul 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jul 2020 — PUBLISHED FOR OPPOSITION
- 08 Jul 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jun 2020 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 16 Jun 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jun 2020 — EXAMINER'S AMENDMENT ENTERED
- 16 Jun 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED